Filters

See more specimen types...

Other countries

Results: 1 to 20 of 30

Tests names and labsConditionsGenes and analytesMethods

New Born testing (CentoICU)

Centogene AG - the Rare Disease Company
Germany
767514
  • C Sequence analysis of the entire coding region

CentoICU platinum plus

Centogene AG - the Rare Disease Company
Germany
768514
  • C Sequence analysis of the entire coding region

Factor XIIIA deficiency

Centogene AG - the Rare Disease Company
Germany
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Genetic Study of Hereditary Thrombophilia (11 genes)

HeartGenetics, Genetics and Biotechnology, SA
Portugal
110
  • E Sequence analysis of select exons
  • T Targeted variant analysis

Congenital Factor XIII deficiency via F13A1 Gene Sequencing with CNV Detection

PreventionGenetics
United States
11
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

F13A1. Complete sequencing

Instituto de Medicina Genomica
Spain
21
  • C Sequence analysis of the entire coding region

Bleeding Disorders Sequencing Panel with CNV Detection

PreventionGenetics
United States
5561
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

F13A1 & F13B gene analysis

Molecular Haemostasis & Thrombosis GSTS Pathology - Guy's and St. Thomas' NHS Foundation Trust
United Kingdom
22
  • C Sequence analysis of the entire coding region

Coagulation Factor Deficiency Sequencing Panel with CNV Detection

PreventionGenetics
United States
2120
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Thrombosis Disorder NGS Panel

Fulgent Genetics
United States
4618
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Primary Immunodeficiency NGS Panel

Fulgent Genetics
United States
1050472
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Thrombosis, Platelet Disorder, and Coagulation Deficiency NGS Panel

Fulgent Genetics
United States
14682
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Coagulation Disorders

Asper Biogene Asper Biogene LLC
Estonia
2717
  • C Sequence analysis of the entire coding region

Thrombophilia due to Factor XIII Deficiency , Massive Sequencing (NGS) F13A1, F13B Genes

Reference Laboratory Genetics
Spain
22
  • C Sequence analysis of the entire coding region

Bleeding Disorders , Panel Massive Sequencing (NGS) 23 Genes

Reference Laboratory Genetics
Spain
2222
  • C Sequence analysis of the entire coding region

Factor XIIIA Deficiency , Sequencing F13A1 Gene

Reference Laboratory Genetics
Spain
11
  • C Sequence analysis of the entire coding region

FACTOR XIII DEFICIENCY

Laboratorio de Genetica Clinica SL
Spain
22
  • C Sequence analysis of the entire coding region

Comprehensive Hematology Panel

Blueprint Genetics
Finland
4239
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Coagulation Factor Deficiency Panel

Blueprint Genetics
Finland
316
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Bleeding Disorder/Coagulopathy Panel

Blueprint Genetics
Finland
762
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 1 to 20 of 30

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.

Support Center